scispace - formally typeset
Open AccessJournal ArticleDOI

Inflammatory Regulation by TLR3 in Acute Hepatitis

TLDR
The data suggest thatTLR3 signaling is necessary for Con A-induced liver damage in vivo and that TLR3 regulates inflammation and the adaptive T cell immune response in the absence of viral infection.
Abstract
TLR3 is known to respond to dsRNA from viruses, apoptotic cells, and/or necrotic cells. Dying cells are a rich source of ligands that can activate TLRs, such as TLR3. TLR3 expressed in the liver is likely to be a mediator of innate activation and inflammation in the liver. The importance of this function of TLR3 during acute hepatitis has not previously been fully explored. We used the mouse model of Con A-induced hepatitis and observed a novel role for TLR3 in hepatocyte damage in the absence of an exogenous viral stimulus. Interestingly, TLR3 expression in liver mononuclear cells and sinus endothelial cells was up-regulated after Con A injection and TLR3−/− mice were protected from Con A-induced hepatitis. Moreover, splenocytes from TLR3−/− mice proliferated less to Con A stimulation in the presence of RNA derived from damaged liver tissue compared with wild-type (WT) mice. To determine the relative contribution of TLR3 expression by hematopoietic cells or nonhematopoietic to liver damage during Con A-induced hepatitis, we generated bone marrow chimeric mice. TLR3−/− mice engrafted with WT hematopoietic cells were protected in a similar manner to WT mice reconstituted with TLR3−/− bone marrow, indicating that TLR3 signaling in both nonhematopoietic and hematopoietic cells plays an important role in mediating liver damage. In summary, our data suggest that TLR3 signaling is necessary for Con A-induced liver damage in vivo and that TLR3 regulates inflammation and the adaptive T cell immune response in the absence of viral infection.

read more

Citations
More filters
Journal ArticleDOI

IL-33/ST2 axis in inflammation and immunopathology

TL;DR: It is observed that IL-33 has attenuated anti-inflammatory effects in T cell-mediated responses and that both IL- 33 and ST2 could be further explored as potential therapeutic targets in treatment of immune-mediated diseases.
Journal ArticleDOI

Protective role of IL-33/ST2 axis in Con A-induced hepatitis.

TL;DR: It is concluded that Interleukin 33/ST2 axis downregulated Concanavalin A-induced liver injury and should be evaluated as potential target in fulminant hepatitis in humans.
Journal ArticleDOI

Melatonin protects liver against ischemia and reperfusion injury through inhibition of toll‐like receptor signaling pathway

TL;DR: It is suggested that melatonin ameliorates I/R‐induced liver damage by modulation of TLR‐mediated inflammatory responses.
Journal ArticleDOI

Integrated intra- and intercellular signaling knowledge for multicellular omics analysis.

TL;DR: OmniPath provides a single access point to knowledge spanning intra‐ and intercellular processes for data analysis, as it demonstrates in applications studying SARS‐CoV‐2 infection and ulcerative colitis.
Journal ArticleDOI

Role of Toll-like receptors in immune activation and tolerance in the liver

TL;DR: The current understanding of TLR signaling and subsequent immune activation and tolerance by the innate immune system in the liver is reviewed, and the dual role of disease-specific TLRs as activators and regulators is clarified.
References
More filters
Journal ArticleDOI

Pathogen Recognition and Innate Immunity

TL;DR: New insights into innate immunity are changing the way the way the authors think about pathogenesis and the treatment of infectious diseases, allergy, and autoimmunity.
Journal ArticleDOI

Toll-like receptor signalling

TL;DR: Rapid progress that has recently improved the understanding of the molecular mechanisms that mediate TLR signalling is reviewed.
Journal ArticleDOI

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.

TL;DR: It is shown that mammalian TLR3 recognizes dsRNA, and that activation of the receptor induces the activation of NF-κB and the production of type I interferons (IFNs).
Journal ArticleDOI

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

TL;DR: The cloning and characterization of a human homologue of the Drosophila toll protein (Toll) is reported, which has been shown to induce the innate immune response in adult Dosophila.
Related Papers (5)